Previous 10 | Next 10 |
2023-06-20 15:55:45 ET RBC Capital Markets has downgraded Abcam ( NASDAQ: ABCM ) to sector perform, advising investors to take profits from the recent spike in valuation amid takeover speculation. Abcam shares have been on a roll in recent days, fueled by a board battle with the...
Files investor presentation; urges shareholders to vote AGAINST all resolutions at July 12 EGM Under CEO Alan Hirzel’s leadership, Abcam has transformed as a business, created significant value for all stakeholders, and outperformed the market The Company is on track to...
2023-06-16 16:25:29 ET BofA has upgraded Abcam ( NASDAQ: ABCM ) to buy, citing improved performance and recent investor activism. In a note released on June 16, BofA commented that Abcam's financial results had improved "markedly" and that the company was "finally delivering on ...
2023-06-16 13:02:23 ET Abcam plc ( NASDAQ: ABCM ) soared 14% after disclosing earlier Friday that it received strategic interest from multiple parties in recent weeks. The British biotech firm was also upgraded to buy at Bank of America. The company's board said it will work...
Highlights progress in delivering on long-term plan and outlines attempts to engage constructively with Dr. Jonathan Milner Asks shareholders to support the Company and vote “AGAINST ” all resolutions to be proposed at the EGM Abcam plc ("Abcam," "Company," "Gr...
2023-06-15 12:47:47 ET Shares in UK-based life sciences company Abcam (NASDAQ: ABCM) were up 12.7% in the week at 11 a.m. ET. The move comes in an exciting week of news for the company, involving an unhappy founder, a leading U.S. activist investor, and the possibility of a lot of d...
2023-06-11 09:00:15 ET Activist investor Starboard Value has taken a stake in UK-based biotech firm Abcam plc ( NASDAQ: ABCM ). Starboard Value, led by Jeff Smith, took a stake of about 2% in Abcam ( ABCM ), according to a Sunday Times report . The disclosure comes a...
2023-06-09 09:00:00 ET Summary Abcam plc's outlook remains unchanged after a mixed FY'22, with improvements needed in fundamental, sentiment, and valuation factors to attract buyers. Despite a strong FY'22, ABCM's poor returns on capital, economic losses and flat growth outlook hi...
ABCAM PLC: Statement on calling an Extraordinary General Meeting PR Newswire CAMBRIDGE, England and WALTHAM, Mass. , May 30, 2023 /PRNewswire/ -- Abcam plc ("Abcam," "Company," "Group") (Nasdaq: ABCM), a global leader in the supply of life science resea...
2023-05-17 18:39:48 ET Jonathan Milner, founder of Abcam ( NASDAQ: ABCM ) and a former director of the company, plans to call for an extraordinary general meeting to win election to the board as executive chairman. In a letter to shareholders earlier Wednesday, he said he wa...
News, Short Squeeze, Breakout and More Instantly...
Danaher Completes Acquisition of Abcam PR Newswire WASHINGTON , Dec. 6, 2023 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher") announced today it has completed its acquisition of Abcam plc (NASDAQ:ABCM) ("Abcam"). The acquisition of Abcam for $24.0...
Abcam plc (Nasdaq: ABCM) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, entered into a definitive agreement on August 26, 2023 relating to its proposed acquisition by Danaher Corporation (NYSE: DHR) ...
2023-11-19 06:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...